1. Bairkdar M., Rossides M., Westerlind H. et al. Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis // Rheumatology (Oxford). 2021. Vol. 60. N. 7. P. 3121–3133. DOI: https://doi.org/10.1093/rheumatology/keab190
2. Alsaidan M., Simmons B.J., Bray F.N. et al. Hippocrates’ contributions to dermatology revealed // JAMA Dermatol. 2015. Vol. 151. N. 6. P. 658. DOI: https://doi.org/10.1001/jamadermatol.2015.0201
3. Wolters M. Beitrag zur Kenntniss der Sclerodermie // Archiv für Dermatologie und Syphilis. 1892. Vol. 24. N. 1. P. 695–738. DOI: https://doi.org/10.1007/bf02445553
4. Rodnan G.P., Benedek T.G. An historical account of the study of progressive systemic sclerosis (diffuse scleroderma) // Ann. Intern. Med. 1962. Vol. 57. P. 305–319. DOI: https://doi.org/10.7326/0003-4819-57-2-305
5. Curzio C. (a) Discussioni Anatomico Pratiche di un raro, e stravagante morbo cutaneo in una giovane Donna felicemente curato in questo grande Ospedale degl’ Incurabili. Giovanni di Simone, Napoli, 1753. (b) Dissertation Anatomique et Pratique sur une Maladie de la Peau, d'une espece fort rare & fort singuliere, translated by Vandermonde. Vincent, Paris, 1755.
6. Watson R. An account of an extraordinary disease of the skin, and its cure. Extracted from the Italian of Carlo Crusio; accompanied with a letter of the Abbe Nollet, F.R.S., to Mr. William Watson, F.R.S. Philos // Trans. R. Soc. Lond. 1754. Vol. 48. P. 579.
7. Capusan I. Sclérodermie ou scléroedème? Commentaires à propos du cas publié en 1753, par le docteur Carlo Curzio, de Naples [Scleroderma or scleroedema? Comments on the case published in 1753 by Dr. Carlo Curzio of Naples] // G. Ital. Dermatol. Minerva Dermatol. 1971. Vol. 46. N. 1. P. 40–47.
8. Capusan I. Curzio’s case of scleroderma // Ann. Intern. Med. 1972. Vol. 76. N. 1. P. 146. DOI: https://doi.org/10.7326/0003-4819-76-1-146_2
9. Остапенко В.М. К истории изучения коллагенозов — системных заболеваний соединительной ткани // Вестник Смоленской государственной медицинской академии. 2002. № 3. С. 77–79.
10. Klemperer P., Pollack A.D., Baehr G. Landmark article May 23, 1942: diffuse collagen disease. Acute disseminated lupus erythematosus and diffuse scleroderma // JAMA. 1984. Vol. 251. N. 12. P. 1593–1594. DOI: https://doi.org/10.1001/jama.251.12.1593
11. Desbois A.C., Cacoub P. Systemic sclerosis: an update in 2016 // Autoimmun. Rev. 2016. Vol. 15. N. 5. P. 417–426. DOI: https://doi.org/10.1016/j.autrev.2016.01.007
12. Katsumoto T.R., Whitfield M.L., Connolly M.K. The pathogenesis of systemic sclerosis // Annu. Rev. Pathol. 2011. Vol. 6. P. 509–537. DOI: https://doi.org/10.1146/annurev-pathol-011110-130312
13. Beesley C.F., Goldman N.R., Taher T.E. et al. Dysregulated B cell function and disease pathogenesis in systemic sclerosis // Front. Immunol. 2023. Vol. 13. Article ID 999008. DOI: https://doi.org/10.3389/fimmu.2022.999008
14. Fox D.A., Lundy S.K., Whitfield M.L. et al. Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis // Arthritis Res. Ther. 2021. Vol. 23. N. 1. P. 1–12. DOI: https://doi.org/10.1186/s13075-020-02383-w
15. Sato S., Fujimoto M., Hasegawa M., Takehara K. Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells // Arthritis Rheum. 2004. Vol. 50. P. 1918–1927. DOI: https://doi.org/10.1002/art.20274
16. Mavropoulos A., Simopoulou T., Varna A. et al. Breg cells are numerically decreased and functionally impaired in patients with systemic sclerosis // Arthritis Rheumatol. 2016. Vol. 68. P. 494–504. DOI: https://doi.org/10.1002/art.39437
17. Soto L., Ferrier A., Aravena O. et al. Systemic sclerosis patients present alterations in the expression of molecules involved in B-cell regulation // Front. Immunol. 2015. Vol. 6. Article ID 496. DOI: https://doi.org/10.3389/fimmu.2015.00496
18. Taher T.E., Ong V.H., Bystrom J. et al. Association of defective regulation of autoreactive interleukin-6-producing transitional B lymphocytes with disease in patients with systemic sclerosis // Arthritis Rheumatol. 2018. Vol. 70. P. 450–461. DOI: https://doi.org/10.1002/art.40390
19. Glauzy S., Olson B., May C.K. et al. Defective early B cell tolerance checkpoints in patients with systemic sclerosis allow the production of self-antigen-specific clones // Arthritis Rheumatol. 2022. Vol. 74. N. 2. P. 307–317. DOI: https://doi.org/10.1002/ART.41927
20. Simon Q., Pers J.O., Cornec D. et al. In-depth characterization of CD24highCD38high transitional human B cells reveals different regulatory profiles // J. Allergy Clin. Immunol. 2016. Vol. 137. P. 1577–1584.e10. DOI: https://doi.org/10.1016/j.jaci.2015.09.014
21. Forestier A., Guerrier T., Jouvray M. et al. Altered B lymphocyte homeostasis and functions in systemic sclerosis // Autoimmun. Rev. 2018. Vol. 17. P. 244–255. DOI: https://doi.org/10.1016/j.autrev.2017.10.015
22. Fielding C.A., Jones G.W., McLoughlin R.M. et al. Interleukin-6 signaling drives fibrosis in unresolved inflammation // Immunity. 2014. Vol. 40. P. 40–50. DOI: https://doi.org/10.1016/j.immuni.2013.10.022